/** blogpostTitle: Rallis Q1 FY27: Strong Domestic Execution, Exports Under Pressure */

Rallis Q1 FY27: Strong Domestic Execution, Exports Under Pressure

Rallis India Limited opened FY27 with a quarter that reflected both strong on-ground execution and a difficult operating environment for agrochemicals. For the quarter ended June 30, 2026 (Q1 FY27), the company reported revenue of 1,022 crore, up 7 percent year on year. EBITDA rose 23 percent to 184 crore, and profit after tax after exceptional items increased 31 percent to 125 crore.

The management described the quarter as one where demand was subdued, pricing pressure continued, and planning was disrupted by multiple factors. These included delayed monsoon, severe heatwave conditions, crop shifts, a reduction in cotton acreage, and the ripple effects of conflict in West Asia that pushed up energy and freight costs. Against this backdrop, Rallis leaned heavily on placement and liquidation execution in domestic formulations and on cost optimization to protect profitability.

The operating context mattered as much as the numbers

Management commentary underlined how volatile the quarter was for the sector. The company pointed to elevated costs, fragile supply chains, and continued dependence on Chinese inputs as structural realities for the industry. Domestically, delayed kharif sowing and rainfall deficits impacted offtake. Management also noted that trade channels rushed to secure fertilizers, causing a cash crunch for crop protection purchases. That, in turn, led to conservative inventory stocking and slower liquidation in the channel.

At the same time, management stressed that the situation was not uniform across crops and regions. Farmers were adapting quickly through crop shifts, and the company expects clearer demand visibility only by mid-August.

Segment performance: domestic strength offsets export weakness

The company’s reported growth in Q1 FY27 was driven primarily by Crop Care and by margin improvement in both Crop Care and Seeds.

Crop Care revenue rose 7 percent year on year to 697 crore. Within Crop Care, domestic B2C was the standout performer, with revenue growing 19 percent to 534 crore, driven by volume growth of 15 percent. The Crop Protection category grew 18 percent to 455 crore, supported by a mix of volume-led growth, aggressive preplacement, and intensified campaign activity.

Soil and Plant Health (SPH) revenue grew 10 percent to 62 crore. Management said the category benefited from pre-placement and a prudent pricing approach intended to protect margins.

The weaker pocket was B2B. Total B2B revenue declined 19 percent year on year to 163 crore. Exports revenue declined 28 percent to 110 crore, primarily due to a 35 percent volume decline. Management attributed this to lower demand for pendimethalin in Europe, competitive China pricing that affected volumes of acephate, Pendi CS, and hexaconazole, and shipping uncertainties linked to logistical challenges.

Custom Synthesis Manufacturing (CSM) revenue, though still small in absolute terms, increased sharply. CSM revenue rose to 24 crore from 8 crore, driven by a rebound in PEKK sales volumes. Management also indicated that shipments have commenced for a new US customer, while reiterating that scaling CSM is a gradual, multi-year process.

Seeds revenue grew 6 percent to 325 crore, driven by price growth of 6 percent. Management acknowledged headwinds from delayed sowings and reduced cotton acreage, along with intense competition in South and Central cotton. The company expects a clearer view on liquidation by end of July.

Execution levers: product launches and digital engagement

Rallis linked the domestic performance to placement discipline, liquidation focus, and a sharper go-to-market rhythm. The company also continued to invest in digital interventions to tighten demand capture and channel engagement.

Management highlighted multiple digital platforms, including Saksham (a GIS tool to identify and cluster high-potential villages), saplpark Plus and Sampark Plus (for capturing demand and insights through farmer interactions), and Anubandh Edge (a retailer-level digital engagement platform). As of June end, retailer registrations on Anubandh Edge crossed 56,000, including seeds and common retailers. The company also runs QR code and reward-based schemes to incentivize farmer purchases.

Product launches were another visible lever. During the quarter, Rallis launched four new crop care products: Balwan and Prodim Ultra (herbicides), Kenigen 20 SC (insecticide), and Aquafert (water soluble fertilizer for ginger and turmeric fertigation). In Seeds, it launched new cotton hybrids for North India and introduced Herbicide Tolerant Direct Seed Rice under the Dhaanya brand. The Seeds business also executed campaign activity focused on liquidation and demand creation, including the Tata Khet campaign.

In CSM, management noted that new customer addition and product scaling are slow but progressing. The company expects 3 to 4 products to mature over the next three years, across stages like advanced registration, pilot production, and early commercialization.

What management said about the road ahead

The management commentary stayed cautious on near-term demand visibility, but offered a few clear directional statements.

On the domestic industry outlook, management said the expectation for FY27 is agrochemicals growth of around 6 to 8 percent in India. This is expected to be aided by pricing, assuming the market stays balanced and avoids aggressive discounting.

Seeds growth was described as mid to high single digits excluding cotton, with cotton expected to remain a challenging category due to acreage decline and the spread of illegal HTBT cotton.

The company also expects better performance in biologicals and SPH than last year, supported by recent improvements in regulatory clarity.

From a financial discipline perspective, the CFO said inventory levels remain elevated compared with the same quarter last year, while collections are smooth. The company reported cash and liquid balance of 309 crore as of June 30, 2026. Working capital days increased by around 15 to 20 days, driven by the cash diversion towards fertilizer purchases in the broader channel.

Takeaways from Q1 FY27

Q1 FY27 showed that Rallis can deliver strong profitability even in a tough season, provided domestic execution is tight and fixed costs are controlled. The domestic B2C business delivered meaningful growth, and Seeds margins improved due to product mix shifting towards higher-margin crops.

At the same time, exports remain exposed to China-led pricing pressure and product-specific competitiveness constraints, especially in acephate. Management’s emphasis on growing CSM and strengthening the portfolio through R and D focus and digital platforms suggests a deliberate attempt to reduce cyclicality and improve quality of earnings over time.

The near-term trajectory, however, still depends heavily on how the monsoon evolves and how crop patterns settle through the season. Management’s own stance is that visibility should improve by mid-August. Until then, the quarter stands as a reminder that in agri inputs, execution matters, but the weather still gets the final vote.